FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

3056511000001109: Cedocard Retard-40 tablets (Pfizer Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17685501000001114 Cedocard Retard-40 tablets (Pfizer Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
38150201000001117 Cedocard Retard 40 tablets (Pfizer Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cedocard Retard-40 tablets (Pfizer Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Cedocard Retard-40 tablets (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Cedocard Retard-40 tablets (Pfizer Ltd) Is a Isosorbide dinitrate 40mg m/r tablet false Inferred relationship Existential restriction modifier
Cedocard Retard-40 tablets (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Cedocard Retard-40 tablets (Pfizer Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Cedocard Retard-40 tablets (Pfizer Ltd) Has active ingredient Osmotic diuretic false Inferred relationship Existential restriction modifier
Cedocard Retard-40 tablets (Pfizer Ltd) Has active ingredient Isosorbide dinitrate true Inferred relationship Existential restriction modifier
Cedocard Retard-40 tablets (Pfizer Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Cedocard Retard-40 tablets (Pfizer Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Cedocard Retard-40 tablets (Pfizer Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Cedocard Retard-40 tablets (Pfizer Ltd) Is a Cedocard Retard true Inferred relationship Existential restriction modifier
Cedocard Retard-40 tablets (Pfizer Ltd) Has specific active ingredient Isosorbide dinitrate true Inferred relationship Existential restriction modifier
Cedocard Retard-40 tablets (Pfizer Ltd) Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Cedocard Retard-40 tablets (Pfizer Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Cedocard Retard-40 tablets (Pfizer Ltd) Is a Isosorbide dinitrate 40mg modified-release tablets false Inferred relationship Existential restriction modifier
Cedocard Retard-40 tablets (Pfizer Ltd) Is a Isosorbide dinitrate 40mg modified-release tablets true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Cedocard Retard-40 tablets (Pfizer Ltd) 60 tablet Is pack of False Cedocard Retard-40 tablets (Pfizer Ltd) Inferred relationship Existential restriction modifier
Cedocard Retard-40 tablets (Pfizer Ltd) 60 tablet Has AMP True Cedocard Retard-40 tablets (Pfizer Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start